The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States
Open accessAbstract
Background. The occurrence of community-associated infections due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli has been recognized as a major clinical problem in Europe and other regions. Methods. We conducted a prospective observational study to examine the occurrence of community-associated infections due to ESBL-producing E. coli at centers in the United States. Five academic and community hospitals and their affiliated clinics participated in this study in 2009 and 2010. Sites of acquisition of the organisms (community-associated or healthcare-associated), risk factors, and clinical outcome were investigated. Screening for the global epidemic sequence type (ST) 131 and determination of the ESBL types was conducted by polymerase chain reaction and sequencing. Results. Of the 291 patients infected or colonized with ESBL-producing E. coli as outpatients or within 48 hours of hospitalization, 107 (36.8%) had community-associated infection (81.5% of which represented urinary tract infection), while the remainder had healthcare-associated infection. Independent risk factors for healthcare-associated infection over community-associated infection were the presence of cardiovascular disease, chronic renal failure, dementia, solid organ malignancy, and hospitalization within the previous 12 months. Of the community-associated infections, 54.2% were caused by the globally epidemic ST131 strain, and 91.3% of the isolates produced CTX-M-type ESBL. Conclusions. A substantial portion of community-onset, ESBL-producing E. coli infections now occur among patients without discernible healthcare-associated risk factors in the United States. This epidemiologic shift has implications for the empiric management of community-associated infection when involvement of E. coli is suspected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Self-citationHoran, T. C., Andrus, M., & Dudeck, M. A. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2008.03.002 · Cited by 6,626
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Self-citationSex and virulence in Escherichia coli: an evolutionary perspective
Wirth, T., Falush, D., Lan, R., Colles, F., Mensa, P., Wieler, L. H., Karch, H., Reeves, P. R., Maiden, M. C. J., Ochman, H., et al. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05172.x · Cited by 2,025
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Friedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668
Resistance Plasmid Families in Enterobacteriaceae
Carattoli, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01707-08 · Cited by 1,229
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Rogers, B. A., Sidjabat, H. E., & Paterson, D. L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq415 · Cited by 716
Self-citationJohnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., & Castanheira, M. (2010) · Clinical Infectious Diseases · doi:10.1086/653932 · Cited by 510
Ben‐Ami, R., Rodríguez‐Baño, J., Arslan, H., Pitout, J. D. D., Quentin, C., Calbo, E. S., Azap, Ö. K., Arpin, C., Pascual, A., Livermore, D. M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/604713 · Cited by 462
Rodríguez-Baño, J., Navarro, M. D., Romero, L., Martínez-Martínez, L., Muniain, M. A., Perea, E. J., Pérez-Cano, R., & Pascual, A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1089-1094.2004 · Cited by 456
Bush, K., & Fisher, J. F. (2011) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102911 · Cited by 419
Clermont, O., Dhanji, H., Upton, M., Gibreel, T., Fox, A., Boyd, D., Mulvey, M. R., Nordmann, P., Ruppe, E., Sarthou, J. L., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp194 · Cited by 357
Clermont, O., Lavollay, M., Vimont, S., Deschamps, C., Forestier, C., Branger, C., Denamur, E., & Arlet, G. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn084 · Cited by 274
Pitout, J. D. D., Gregson, D. B., Church, D. L., Elsayed, S., & Laupland, K. B. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2844-2849.2005 · Cited by 158
Sidjabat, H. E., Paterson, D. L., Adams‐Haduch, J. M., Ewan, L., Pasculle, A. W., Muto, C. A., Tian, G., & Doi, Y. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00533-09 · Cited by 146
Self-citationJohnson, J. R., Urban, C. M., Weissman, S. J., Jorgensen, J. H., Lewis, J. S., Hansen, G. T., Edelstein, P. H., Robicsek, A. A., Cleary, T., Adachi, J. A., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05824-11 · Cited by 117
Self-citationJohnson, J. R., Porter, S. B., Zhanel, G. G., Kuskowski, M. A., & Denamur, É. (2012) · Infection and Immunity · doi:10.1128/iai.06388-11 · Cited by 114
Apisarnthanarak, A., Kiratisin, P., Saifon, P., Kitphati, R., Dejsirilert, S., & Mundy, L. M. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.05.008 · Cited by 89
Robberts, F. J. L., Kohner, P. C., & Patel, R. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01687-08 · Cited by 89
Virulence Potential and Genomic Mapping of the Worldwide Clone Escherichia coli ST131
Lavigne, J., Vergunst, A. C., Goret, L., Sotto, A., Combescure, C., Blanco, J., O’Callaghan, D., & Nicolas-Chanoine, M.-H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034294 · Cited by 88
Minarini, L. A. D. R., Gales, A. C., Palazzo, I. C. V., & Darini, A. L. D. C. (2007) · Current Microbiology · doi:10.1007/s00284-006-0307-z · Cited by 88
Yumuk, Z., Afacan, G., Nicolas-Chanoine, M.-H., Sotto, A., & Lavigne, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn181 · Cited by 86
Cheong, H. S., Kang, C., Kwon, K. T., Heo, S. T., Wi, Y. M., Kim, E., Lee, J., Ko, K. S., Chung, D. R., Lee, N. Y., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm378 · Cited by 69
Kim, Y. A., Qureshi, Z. A., Adams‐Haduch, J. M., Park, Y. S., Shutt, K. A., & Doi, Y. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis387 · Cited by 53
Self-citationCommunity-acquired Extended-Spectrum β-Lactamase Producers, United States
Doi, Y., Adams, J. M., O’Keefe, A., Qureshi, Z. A., Ewan, L., & Paterson, D. L. (2007) · Emerging infectious diseases · doi:10.3201/eid1307.070094 · Cited by 50
Self-citationKang, C., Cheong, H. S., Chung, D. R., Peck, K. R., Song, J., Oh, M., & Choe, K. W. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0401-6 · Cited by 49
Clark, G., Paszkiewicz, K. H., Hale, J., Weston, V., Constantinidou, C., Penn, C. W., Achtman, M., & McNally, A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr585 · Cited by 49
Moor, C. T., Roberts, S., Simmons, G., Briggs, S. E., Morris, A. J., Smith, J., & Heffernan, H. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.02.003 · Cited by 43
Freeman, J. T., Sexton, D. J., & Anderson, D. J. (2009) · Clinical Infectious Diseases · doi:10.1086/600046 · Cited by 26
Cited by
Simonsen, K. A., Anderson-Berry, A. L., Delair, S. F., & Davies, H. D. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-13 · Cited by 984
Escherichia coli ST131, an Intriguing Clonal Group
Nicolas-Chanoine, M.-H., Bertrand, X., & Madec, J.-Y. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00125-13 · Cited by 895
Harris, P. N. A., Tambyah, P. A., Lye, D. C., Mo, Y., Lee, T. H., Yilmaz, M., Alenazi, T. H., Arabi, Y., Falcone, M., Bassetti, M., et al. (2018) · JAMA · doi:10.1001/jama.2018.12163 · Cited by 774
Self-citationMultidrug-Resistant Bacteria in the Community
van Duin, D., & Paterson, D. L. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.004 · Cited by 584
Self-citationMultidrug-resistant bacterial infections in U.S. hospitalized patients, 2012-2017.
Jernigan, J. A., Hatfield, K. M., Wolford, H., Nelson, R. E., Olubajo, B., Reddy, S. C., McCarthy, N., Paul, P., McDonald, L. C., Kallen, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1914433 · Cited by 577
Metadata
- Authors
- Doi, Y., Park, Y. S., Rivera, J. I., Adams-Haduch, J. M., Hingwe, A., Sordillo, E. M., Lewis, J. S., Howard, W. J., Johnson, L. E., Polsky, B., Jorgensen, J. H., Richter, S. S., Shutt, K. A., & Paterson, D. L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-11-13
- Volume
- 56
- Issue
- 5
- Pages
- 641-648
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2167495142
- Cited by
- 303
- References
- 30
- FWCI
- 12.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.